Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius : makes solid start to 2019 and confirms Group guidance

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/02/2019 | 01:33am EDT
  • Contact

    Matthias Link

    Vice President Corporate Communications
    T: +49 (0) 6172 608-2872
    matthias.link@fresenius.com

  • Documents

You will find the full text of the message here shortly. Until then, you can download the press release as a PDF file.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Disclaimer

Fresenius SE & Co. KGaA published this content on 02 May 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 May 2019 05:32:04 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO. KGAA
10/16FRESENIUS : celebrates expansion of Bad Homburg headquarters
PU
10/08Deutsche Bank's chairman best paid among German blue chips in 2018
RE
10/07FRESENIUS : Kabi launches Fulvestrant in prefilled syringes in the U.S.
PU
09/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the Germa..
EQ
09/16FRESENIUS : 2020 DRG inflator for German hospitals set at 3.66%
PU
09/15Fresenius drops possible sale of blood transfusion unit - spokesman
RE
09/13FRESENIUS SE & CO. KGAA : Release according to Article 40, Section 1 of the WpHG..
EQ
09/11FRESENIUS : Helios launches digital portal for patients
PU
09/09FRESENIUS : Medical Care's publishes annual medical report
PU
09/06FRESENIUS : Medical Care builds new laboratory in Mississippi
PU
More news
Financials (EUR)
Sales 2019 35 389 M
EBIT 2019 4 676 M
Net income 2019 1 846 M
Debt 2019 20 659 M
Yield 2019 1,85%
P/E ratio 2019 13,1x
P/E ratio 2020 12,0x
EV / Sales2019 1,27x
EV / Sales2020 1,11x
Capitalization 24 163 M
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 56,25  €
Last Close Price 43,37  €
Spread / Highest target 72,5%
Spread / Average Target 29,7%
Spread / Lowest Target -25,2%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors